Merck (MRK) is set to present new clinical trial data at the European Society of Cardiology Congress 2025, emphasizing advancements in cardiovascular disease management. Over the last quarter, Merck's ...

Boston— Allarity Therapeutics, Inc., a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib— a differentiated dual PARP/Wnt pathway inhibitor— announced the ...

Data featured in oral presentation and poster session at 48th European Cystic Fibrosis Conference WALTHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a ...

Oral presentation of RAMP 201 trial results including updated subgroup analyses in recurrent low-grade serous ovarian cancer Oral presentation of investigator-sponsored study of avutometinib plus ...

Molecular Partners (MOLN) and Orano Med announced the oral presentation of the latest preclinical data supporting MP0712 as a Radio-DARPin Therapeutic, or RDT, at the European Assocation of ...

Dear Editor A FREQUENTLY used cautionary adage among competent analysts is that “Statistics don’t lie, liars use statistics.” Quite often, this adage also ...